11:56am Sunday 17 December 2017

Live Donor Liver Transplantation Found Safe and Effective for Acute Liver Failure

If untreated, acute liver failure results in coma and death in more than 80 percent of cases. The only effective therapy is liver transplantation, but the deceased donor supply of livers is often not timely enough. Live donor liver transplantation (LDLT) is an attractive option to overcome this problem, but studies haven’t looked at the safety of the procedure for acute liver failure patients or donors who may have to have last-minute examinations to determine their compatibility. Also, experts worry that individuals perhaps should not be allowed to make donor-related decisions when faced with the death of a loved one, although denying someone the opportunity to save a loved one’s life is sub-optimal as well.

Markus Selzner, MD, of the Multi-Organ Transplant Program at Toronto General Hospital, and his colleagues now report on their hospital’s experience using LDLT for treating adult patients suffering from acute liver failure. From 2006 to 2013, all seven patients with acute liver failure who underwent a LDLT were compared with all 26 patients who underwent a deceased donor liver transplantation (DDLT). For LDLT, liver transplantation was performed within 18 to 72 hours after living donor evaluation was initiated.

LDLT versus DDLT had similar incidences of overall postoperative complications (31% versus 43%), and no differences were detected between LDLT and DDLT patients regarding 1-, 3-, and 5-year liver and patient survival rates. No severe donor complications occurred after LDLT.

“Since acute liver failure can deteriorate within hours or days to coma or death, waiting time is critical for this patient group,” said Dr. Selzner. “If a living donor is available, liver transplantation can be performed without delay, reducing the risk of death or permanent disability of the recipient.”

In an accompanying editorial, Jean Emond, MD, of Columbia University in New York City, and Charles Rosen, MD, of the Mayo Clinic in Rochester, Minnesota, congratulate the researchers for their pioneering work. They noted, however, that “further experience is necessary to demonstrate that urgent evaluations can be done safely, accurately, and with avoidance of coercion and undue stress on potential donors and their families.”

Media wishing to receive a PDF of this article may contact sciencenewsroom@wiley.com. (Would you prefer to access this paper instantly? You can register for a login to our Press Room here.)

Full citation: “Live donor liver transplantation: A valid alternative for critically ill patients suffering from acute liver failure.” Nicolas Goldaracena, Vinzent N. Spetzler, Max Marquez, Nazia Selzner, Mark S. Cattral, Paul D. Greig, Les Lilly, Ian D. McGilvray, Gary A. Levy, Anand Ghanekar, Eberhard L. Renner, David R. Grant, and Markus Selzner. American Journal of Transplantation; Published Online: March 19, 2015 (DOI: 10.1111/ajt.13203).
URL: http://doi.wiley.com/10.1111/ajt.13203

Editorial: “Living Donor Liver Transplantation in emergencies: Is it time to say yes?” Jean Emond and Charles Rosen. American Journal of Transplantation

About the Author:
To arrange an interview with the author, please contact Alexandra Radkewycz of Toronto General Hospital’s public affairs office at +1 (416) 340-3895 or Alexandra.Radkewycz@uhn.ca.

About the Journal:
American Journal of Transplantation (AJT) is the official journal of the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS). This #1 ranked transplantation journal serves as a forum for debate and re-assessment and is a major platform for promoting understanding, improving results and advancing science in this dynamic field. Published monthly, AJT provides an essential resource for researchers and clinicians around the world. Find out more at www.amjtransplant.com.

About Wiley
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.

Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley’s global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company’s website can be accessed at http://www.wiley.com.

Media Contacts:
Evelyn Martinez (US) +1 201 748 6358
Tom Griffin (UK) +44 (0) 1865 476213
sciencenewsroom@wiley.com


Share on:
or:

MORE FROM Surgery and Rehabilitation

Health news